274 related articles for article (PubMed ID: 27084634)
1. Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.
Gameiro SR; Malamas AS; Bernstein MB; Tsang KY; Vassantachart A; Sahoo N; Tailor R; Pidikiti R; Guha CP; Hahn SM; Krishnan S; Hodge JW
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):120-130. PubMed ID: 27084634
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing.
Gameiro SR; Jammeh ML; Wattenberg MM; Tsang KY; Ferrone S; Hodge JW
Oncotarget; 2014 Jan; 5(2):403-16. PubMed ID: 24480782
[TBL] [Abstract][Full Text] [Related]
3. Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation.
Malamas AS; Gameiro SR; Knudson KM; Hodge JW
Oncotarget; 2016 Dec; 7(52):86937-86947. PubMed ID: 27893426
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Hodge JW; Garnett CT; Farsaci B; Palena C; Tsang KY; Ferrone S; Gameiro SR
Int J Cancer; 2013 Aug; 133(3):624-36. PubMed ID: 23364915
[TBL] [Abstract][Full Text] [Related]
5. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes.
Garnett CT; Palena C; Chakraborty M; Tsang KY; Schlom J; Hodge JW
Cancer Res; 2004 Nov; 64(21):7985-94. PubMed ID: 15520206
[TBL] [Abstract][Full Text] [Related]
6. The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing.
Chakraborty M; Wansley EK; Carrasquillo JA; Yu S; Paik CH; Camphausen K; Becker MD; Goeckeler WF; Schlom J; Hodge JW
Clin Cancer Res; 2008 Jul; 14(13):4241-9. PubMed ID: 18594006
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
8. Protons versus photons for the treatment of chordoma.
El Sayed I; Trifiletti DM; Lehrer EJ; Showalter TN; Dutta SW
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013224. PubMed ID: 34196007
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.
Gelbard A; Garnett CT; Abrams SI; Patel V; Gutkind JS; Palena C; Tsang KY; Schlom J; Hodge JW
Clin Cancer Res; 2006 Mar; 12(6):1897-905. PubMed ID: 16551875
[TBL] [Abstract][Full Text] [Related]
10. Optimization of combined proton-photon treatments.
Unkelbach J; Bangert M; De Amorim Bernstein K; Andratschke N; Guckenberger M
Radiother Oncol; 2018 Jul; 128(1):133-138. PubMed ID: 29370987
[TBL] [Abstract][Full Text] [Related]
11. Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.
Gameiro SR; Caballero JA; Hodge JW
Cancer Biother Radiopharm; 2012 Feb; 27(1):23-35. PubMed ID: 22316209
[TBL] [Abstract][Full Text] [Related]
12. Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy.
Wattenberg MM; Fahim A; Ahmed MM; Hodge JW
Radiat Res; 2014 Aug; 182(2):126-38. PubMed ID: 24960415
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions.
Bernstein MB; Garnett CT; Zhang H; Velcich A; Wattenberg MM; Gameiro SR; Kalnicki S; Hodge JW; Guha C
Cancer Biother Radiopharm; 2014 May; 29(4):153-61. PubMed ID: 24693958
[TBL] [Abstract][Full Text] [Related]
14. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
Beauford SS; Kumari A; Garnett-Benson C
BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
[TBL] [Abstract][Full Text] [Related]
15. Tecemotide: an antigen-specific cancer immunotherapy.
Wurz GT; Kao CJ; Wolf M; DeGregorio MW
Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules.
Wang HT; Lee HI; Guo JH; Chen SH; Liao ZK; Huang KW; Torng PL; Hwang LH
Int J Cancer; 2012 Jun; 130(12):2892-902. PubMed ID: 21805477
[TBL] [Abstract][Full Text] [Related]
17. Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.
Kabolizadeh P; Chen YL; Liebsch N; Hornicek FJ; Schwab JH; Choy E; Rosenthal DI; Niemierko A; DeLaney TF
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):254-262. PubMed ID: 27986348
[TBL] [Abstract][Full Text] [Related]
18. A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines.
Donahue RN; Duncan BB; Fry TJ; Jones B; Bachovchin WW; Kiritsy CP; Lai JH; Wu W; Zhao P; Liu Y; Tsang KY; Hodge JW
Vaccine; 2014 May; 32(26):3223-31. PubMed ID: 24731809
[TBL] [Abstract][Full Text] [Related]
19. Accounting for Range Uncertainties in the Optimization of Combined Proton-Photon Treatments Via Stochastic Optimization.
Fabiano S; Bangert M; Guckenberger M; Unkelbach J
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):792-801. PubMed ID: 32361008
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of classical and non-classical HLA molecules by ionizing radiation.
Gallegos CE; Michelin S; Dubner D; Carosella ED
Cell Immunol; 2016 May; 303():16-23. PubMed ID: 27113815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
